dihydroxyphenylalanine has been researched along with Dysplastic Nevus Syndrome in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Dysplastic Nevus Syndrome: Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether plasma 5-S-cysteinyldopa levels are useful in following up patients at risk for melanoma, we measured plasma 5-S-cysteinyldopa in patients with dysplastic nevus syndrome and/or malignant melanoma and in control subjects." | 7.67 | Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. ( Fletcher, WS; Ilias, A; Palmquist, M; Peterson, LL; Tucker, MA; Woodward, WR, 1988) |
| "To determine whether plasma 5-S-cysteinyldopa levels are useful in following up patients at risk for melanoma, we measured plasma 5-S-cysteinyldopa in patients with dysplastic nevus syndrome and/or malignant melanoma and in control subjects." | 3.67 | Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. ( Fletcher, WS; Ilias, A; Palmquist, M; Peterson, LL; Tucker, MA; Woodward, WR, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, LL | 1 |
| Woodward, WR | 1 |
| Fletcher, WS | 1 |
| Palmquist, M | 1 |
| Tucker, MA | 1 |
| Ilias, A | 1 |
| Stierner, U | 1 |
| Augustsson, A | 1 |
| Rosdahl, I | 1 |
| Kågedal, B | 1 |
| Suurküla, M | 1 |
2 other studies available for dihydroxyphenylalanine and Dysplastic Nevus Syndrome
| Article | Year |
|---|---|
Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects.
Topics: Adult; Aged; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Cysteinyldopa; Diagnosis, Diff | 1988 |
UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
Topics: Adult; Aged; Cell Count; Cell Division; Chromatography, High Pressure Liquid; Cysteinyldopa; Dihydro | 1988 |